Best SurfingNASH.com Podcasts (2025)

1
S6 - E6 - Remembering Stephen Harrison and His Many Contributions to MASH 57:17

10d ago57:17

57:17

00:00:00 Surf's Up, Season 6, Episode 6. On April 23, 2024, our colleague and co-founder, Stephen Harrison, passed away suddenly. This week, Surfing the MASH Tsunami remembers Stephen with two of his closest associates and continues our annual MASH Drug Development roundtable held in his honor. 00:00:04:24 - A Deep Dive into Drug Development, Part …

1
S6 - E5.2 - Newsmaker: Naga Chalasani on Real-World Experience Prescribing Resmetirom 26:18

11d ago26:18

26:18

This weekend’s Newsmaker, Indiana University hepatologist and key opinion leader Naga Chalasani, joins Roger Green to discuss Early Experience with Resmetirom To Treat Metabolic-Associated Steatohepatitis with Fibrosis in a Real-World Setting, an article his group published recently in Hepatology Communications. He shares highlights from the paper …

1
S6 - E5.3 - Expert: Scott Friedman on Gene Therapy and Advances in Liver Science 23:23

11d ago23:23

23:23

This week’s expert, Hepatologist and Key Opinion Leader Scott Friedman, joins Roger to discuss advances in acceptance of gene therapy and knowledge in other areas of basic liver science. When discussing science, he pays particular attention to findings on the diversity of stellate cells and his interest in CAR-T as a therapy for liver disease. This…

1
S6 - E5.1 - FGF-21s and A Promising Future on Cirrhosis 24:24

13d ago24:24

24:24

This conversation is the opening segment of SurfingMASH's April discussion, in memory of Stephen A. Harrison, on drug development. In addition to co-hosts Jörn Schattenberg, Louise Campbell and Roger Green, panelists include hepatologists and key opinion leaders Sven Francque and Naim Alkhouri. This opening discussion focuses on exciting advances i…

1
S6 - E5 - Drug Development Week: FGF-21s, Cirrhosis, Resmiterom, Gene Therapies 1:09:00

17d ago1:09:00

1:09:00

00:00:00 - Surf's Up: Season 6 Episode 5 Host Roger Green briefly describes this episode’s three sections and introduces Roundtable guests. The Roundtable panel shares groundbreakers. 00:10:39 - Roundtable: A Deep Dive Into Drug Development, Part One The opening portion of this month's roundtable centers around two issues: exciting data for FGF-21s…

1
S6 - E4.3 - Expert: Mazen Noureddin Reviews the Exciting MASLD Drug Development Environment 24:34

23d ago24:34

24:34

This week's expert, Hepatologist and Key Opinion Leader Mazen Noureddin, joins Roger to discuss major advances in drug development over the past year. He covers a range of different drug classes, focusing on stages of development and the range of options within each class. First, Mazen discusses a tremendously exciting group of FGF-21 agents, speci…

1
S6 - E4.2 - Newsmaker: Fatty Liver Alliance Founder Mike Betel Discusses the Increased Visibility of Patient Advocates 31:16

23d ago31:16

31:16

This weekend's Newsmaker, Fatty Liver Alliance Founder Mike Betel, joins Roger Green to discuss the wide range of conferences where he has been invited to speak or sit on a panel this year. Specifically, he shares his belief on what this says about interest in MASLD and describes the messages he delivers at the conferences he attends. The interview…

1
S6 - E4.1 - MASLD Drugs, SLD Spectrum Insights Suggest Bright Future 20:58

23d ago20:58

20:58

This conversation is the concluding segment of SurfingMASH's coverage of the AASLD Emerging Trends Conference on the SLD Spectrum diseases: MASLD, MetALD and ALD. In addition to co-hosts Louise Campbell and Roger Green, panelists include EASL Secretary General Aleksander Krag, hepatologist Alex Lalos and Jenn Leigh Jones, Founder of the Society for…

1
S6 - E4 - Reasons for optimism in MASLD drug development and patient advocacy 1:12:42

24d ago1:12:42

1:12:42

00:00:00 - Surf's Up: Season 6 Episode 4 Surfing the MASH Tsunami concludes its coverage of the AASLD Emerging Trends Conference on MASLD, MetALD and ALD. This week, the panelists focus on pivotal messages that attendees took away from the conference and what messages they would like to share with listeners. Our newsmaker, Fatty Liver Alliance and …

1
S6 - E3.3 - Expert: GLI's Jeff McIntyre discusses implications of FDA job cuts on MASH drugs 31:31

30d ago31:31

31:31

This week's Expert is Jeff McIntyre, Vice President, Liver Programs at the Global Liver Institute. His major topic is how recent high-level FDA job cuts might affect MASH drug and diagnostics development. He also shares reactions to FibroSIGHT, HistoIndex's new digital pathology service for clinical practice. Highlight: Recent job cuts at the FDA w…

1
S6 E3.2 - Newsmakers: FibroSIGHT™ Brings Clinical Trial Analytics to the Clinic 28:57

1M ago28:57

28:57

This week's newsmaker, Yukti Choudhury, Director of Clinical Development at HistoIndex, joins Roger Green to discuss FibroSIGHT, a new HistoIndex service that allows clinicians to use HistoIndex's Second Harmonic Generation (SHG) technology and analytics to determine specific CRN fibrosis level for patients with inconclusive NIT results. One reason…

1
S6- E3.1 - Roundtable: Spotting Tomorrow’s Trends in Today's MASLD Studies 15:02

1M ago15:02

15:02

Surfing the MASH Tsunami continues its coverage of the AASLD Emerging Trends Conference on MASLD, MetALD and ALD. This week, the panelists focus on what studies on bariatric surgery and drugs in development can tell us about future treatment and explore some clinical trial questions. Guest Surfers include Professor Aleksander Krag of the University…

1
S6 - E3 - Drugs and Diagnostics Evolve as the FDA Devolves 1:12:31

1M ago1:12:31

1:12:31

00:00:00 - Surf's Up: Season 6 Episode 3 Surfing the MASH Tsunami continues its coverage of the AASLD Emerging Trends Conference on MASLD, MetALD and ALD. This week, the panelists focus on what studies on bariatric surgery and drugs in development can tell us about future treatment and explore some clinical trial questions. Our newsmaker, HistoInde…

1
S6 - E2 - MetALD Epidemiology, MASLD Mortality and a PCP "Unicorn" 1:11:36

1M ago1:11:36

1:11:36

00:00:00 - Surf's Up: Season 6 Episode 2 Surfing the MASH Tsunami continues its coverage of the AASLD Emerging Trends Conference on MASLD, MetALD and ALD. This week, the panelists focus on disease epidemiology and what it can teach us about the relative importance of alcohol and diet on disease progression. Our newsmaker, hepatology KOL and frequen…

1
S6 - E1: Two Multispecialty February Conferences and Europe Prepares for Resmetirom 1:13:24

2M ago1:13:24

1:13:24

00:00:00 - Surf's Up! Season 6 Episode 1 SurfingMASH kicks off our sixth season in our new format, with three major elements to each episode. This week's Roundtable and Newsmakers segments focused on two recent conferences that took a multispecialty perspective on the range of medical and psychological issues affecting steatotic liver disease (a ne…

1
S5 - E26.5 - Looking Back at #TLM2024 - Promoting Healthy Livers and Looking Ahead to 2025 15:18

4M ago15:18

15:18

In this episode, Naim Alkhouri, Mike Betel, Michelle Long and Jeff McIntyre join Jörn Schattenberg and Roger Green to look back at The Liver Meeting 2024. This conversation reviews two sessions promoting healthy livers and asks panelists what they anticipate for #TLM2025. This last conversation starts with Jeff describing the session that moved him…

1
S5 - E26.4 - Looking Back at #TLM2024 - Patient Advocacy and Patient-Centric Trials 11:44

4M ago11:44

11:44

In this episode, Naim Alkhouri, Mike Betel, Michelle Long and Jeff McIntyre join Jörn Schattenberg and Roger Green to look back at The Liver Meeting 2024. This conversation considers the role of patient advocacy in replacing biopsy in clinical trials with NITs and reviews a session on the foundational principles for patien-centric clinical trials. …

1
S5 - E26.2 - Looking Back at #TLM2024 - Patient Genotyping and MASH Clusters 14:27

4M ago14:27

14:27

In this episode, Naim Alkhouri, Mike Betel, Michelle Long and Jeff McIntyre join Jörn Schattenberg and Roger Green to look back at The Liver Meeting 2024. This conversation considers how the anticipated approval of a second MASH drug without biopsy might affect clinical trials and discusses two recent publications on patient genotyping and patient …

1
S5 - E26.3 - Looking Back at #TLM2024 - FGF-21 Agents and the FDA Corner 13:18

4M ago13:18

13:18

In this episode, Naim Alkhouri, Mike Betel, Michelle Long and Jeff McIntyre join Jörn Schattenberg and Roger Green to look back at The Liver Meeting 2024. This conversation reviews the late-breaker presentation on efimosermin, a q4w FGF-21 agent and the "FDA Corner" session. Jörn begins the discussion by highlighting a paper from the later breaker …

1
S5 - E26.1 - Looking Back at #TLM2024 - Semaglutide Passes the ESSENCE Test 13:32

4M ago13:32

13:32

In this episode, Naim Alkhouri, Mike Betel, Michelle Long and Jeff McIntyre join Jörn Schattenberg and Roger Green to look back at The Liver Meeting 2024. This conversation reviews the ESSENCE trial, the Phase 3 trial demonstrating that semaglutide regresses fibrosis levels in some MASH patients. The conversation begins with each panelist sharing a…

1
S5-26 - One Month Later: Looking Back at MASLD/MASH Coverage From The Liver Meeting 2024 1:11:25

5M ago1:11:25

1:11:25

00:00:00 – Surf’s Up: Season 5 Episode 26 - Last month, close to 8,000 hepatology stakeholders convened in San Diego for The Liver Meeting 2024. Hepatology Key Opinion Leader Naim Alkhouri, Novo Nordisk International Vice President for Medicines Michelle Long, and patient advocates Jeff McIntyre from the Global Liver Institute and Michael Betel fro…

1
S5 - E25 - Reviewing Expert Recommendations on the Use of Resmetirom 42:02

9M ago42:02

42:02

By HEP Dynamics LLC

1
S4 - E24.5 - SurfingMASH Question of The Week: Keys to Improving Provider-Patient Communication 20:14

9M ago20:14

20:14

Two weeks ago, the SurfingMASH Question of the Week asked, "What structural or educational changes do you anticipate will significantly improve Provider-Patient communication? Will these changes require more from the provider and more from the patient?" Today, S5 E23 panelists Mike Betel and José Willemse join Roger Green to review the three answer…

1
S5 - E24.4 - EASL Congress Six Weeks Later: Jeff McIntyre's Key Implications for GLI 18:28

9M ago18:28

18:28

In the second half of Roger Green's interview with Global Liver Institute Vice President, Liver Programs Jeff McIntyre, Jeff discusses the implications of his key EASL Congress takeaways for GLI and other patient advocacy groups. To Jeff, this trend makes patient advocates a more valuable player in the clinical trial design process, particularly wh…

1
S5 - E24.3 - EASL Congress Six Weeks Later: Jeff McIntyre's Key Takeaways 12:46

9M ago12:46

12:46

This conversation contains the first half of Roger Green's interview with Global Liver Institute Vice President, Liver Programs Jeff McIntyre, during which the two discuss what Jeff considered the key strategic takeaways for GLI from the various EASL Congress presentations, abstracts and discussions. Jeff focuses on the "overriding sense of optimis…

1
S5 - E24.2 - EASL Congress Six Weeks Later: Mathieu Petitjean's Key Implications 10:58

9M ago10:58

10:58

In the second half of Roger Green's interview with PharmaNest Founder and CEO Mathieu Petitjean, Matt discusses the implications of his key EASL Congress takeaways for PharmaNest. Matt starts this discussion with a simple question: Will biopsy-based analyses become part of a surrogate endpoint? As he points out, they are not today, and creating the…

1
S5 - E24.1 - EASL Congress Six Weeks Later: Mathieu Petitjean's Key Takeaways 17:10

9M ago17:10

17:10

This conversation contains the first half of Roger Green's interview with PharmaNest Founder and CEO Mathieu Petitjean. After Matt tells the audience a little about his background and PhramaNest, the two discuss what Matt considered the key strategic takeaways for PharmaNest from the various EASL Congress presentations, abstracts and discussions. B…

1
S5 - E24 - A view of MASLD: Looking back at EASL Congress from six weeks later 1:16:26

9M ago1:16:26

1:16:26

00:00:00 - Surf's Up: Season 5 Episode 24 This week's episode on MASLD lessons from the EASL Congress 2024 includes three separate elements: individual interviews with PharmaNext Founder and CEO Mathieu Petitjean and Global Liver Institute Vice President of Liver Programs Jeff McIntyre, followed by a discussion with patient advocates Mike Betel of …

1
S5 SPECIAL 5 - Reviewing EASL Congress: Louise Campbell 3 (first-time material) 9:48

10M ago9:48

9:48

This week, Surfing the MASH Tsunami looks back on interviews Roger Green conducted during the EASL Congress itself. This conversation with SurfingMASH co-host and Tawazun Health Founder and Clinical Director Louise Campbell took place on the last day of the Congress This portion of the conversation was not included in the original S5 E19 but instea…

1
S5 SPECIAL 4 - Reviewing EASL Congress: Sven Francque 17:12

10M ago17:12

17:12

This week, Surfing the MASH Tsunami looks back on interviews Roger Green conducted during the EASL Congress itself. This conversation with Hepatology Key Opinion Leader and EASL Educational Councillor Sven Francque took place 90 minutes after the EASL Congress closed. The discussion focuses on plans and hopes for the future, both the future of MASL…

1
S5 SPECIAL 3 - Reviewing EASL Congress: Louise Campbell 2 20:47

10M ago20:47

20:47

This week, Surfing the MASH Tsunami looks back on interviews Roger Green conducted during the EASL Congress itself. This conversation with SurfingMASH co-host and Tawazun Health Founder and Clinical Director Louise Campbell took place on the last day of the Congress. This conversation centered on three major topics addressed at the EASL Congress, e…

1
S5 SPECIAL 2 - Reviewing EASL Congress: Louise Campbell I 20:13

10M ago20:13

20:13

This week, Surfing the MASH Tsunami looks back on interviews Roger Green conducted during the EASL Congress itself. This conversation with SurfingMASH co-host and Tawazun Health Founder and Clinical Director Louise Campbell took place on the first day of the Congress. Roger's first interview with Louise took place at the end of Thursday, the openin…

1
S5 SPECIAL 1 - Reviewing EASL Congress: Mike Betel 13:04

10M ago13:04

13:04

This week, Surfing the MASH Tsunami looks back on interviews Roger Green conducted during the EASL Congress itself. This conversation with Fatty Liver Alliance Founder and CEO Mike Betel took place Wednesday of Congress week, a day for special sections and industry presentations, but one day before the General Session opened. The first part of the …

1
S5 - E23.6 - From The Vault: Improving Patient Self-Management And Key Takeaways On Nutrition For MASH Resolution 29:50

10M ago29:50

29:50

This week’s vault comes from our first episode with Shira Zelber-Sagi. She and Ken Cusi joined us during US Thanksgiving Week 2022 to discuss nutrition and behavioral issues related to MASLD. The episode’s original writeup explains: Surfing the MASH Tsunami hosts its first episode dedicated to nutrition and NASH with distinguished guest, Prof. Shir…

1
S5 - E23.5 - From the EASL Congress: The Need for Shared Experience MASLD Support Groups and Programs 11:45

10M ago11:45

11:45

Co-chairs Shira Zelber-Sagi and Mike Betel and panelists Tom Marjot and José Willemse, all from the EASL Congress session "Patient Experiences in Clinical Settings," join Louise Campbell to the need for resources that allow MASLD patients to access shared experience programs and holistic MASLD support programs. This final conversation focuses on sh…

1
S5 - E23.4 - From the EASL Congress: Socioeconomic And Psychological Issues In The Physician-Patient Dialogue 12:20

10M ago12:20

12:20

Co-chairs Shira Zelber-Sagi and Mike Betel and panelists Tom Marjot and José Willemse, all from the EASL Congress session "Patient Experiences in Clinical Settings," join Louise Campbell to discuss ways that socioeconomic and psychological issues impact the dynamic of the physician-patient consult, and, as a result, often patient adherence to thera…

1
S5 - E23.3 - From The EASL Congress: Improving The Physician-Patient Dialogue 12:25

10M ago12:25

12:25

Co-chairs Shira Zelber-Sagi and Mike Betel and panelists Tom Marjot and José Willemse, all from the EASL Congress session "Patient Experiences in Clinical Settings," join Louise Campbell to discuss strategies and questioning styles that can improve the dynamic of the physician-patient consult. This conversation starts with Tom stating that having m…

1
S5 - E23.2 - From The EASL Congress: Dynamics Of The Physician-Patient Dialogue 11:29

10M ago11:29

11:29

Co-chairs Shira Zelber-Sagi and Mike Betel and panelists Tom Marjot and José Willemse, all from the EASL Congress session "Patient Experiences in Clinical Settings," join Louise Campbell to discuss some of the key dynamics shaping the physician-patient consult. This conversation starts with Mike asking Tom whether he reviews the patient's history b…

1
S5 - E23.1 - From The EASL Congress: Overview Of Challenges In Physician-Patient Communication 14:38

10M ago14:38

14:38

Co-chairs Shira Zelber-Sagi and Mike Betel and panelists Tom Marjot and José Willemse, all from the EASL Congress session "Patient Experiences in Clinical Settings," join Louise Campbell to provide an overview of issues in physician-patient communication. The conversation itself has two elements. It starts with first-time surfers Tom Marjot and Jos…

1
S5 - E23 - Lessons from EASL Congress: Challenges in Provider-Patient Communication 58:52

10M ago58:52

58:52

00:00:00 - Surf's Up: Season 5 Episode 23 During SurfingMASH's wrap-up interviews from the EASL Congress (S5 E19), Louise Campbell and Mike Betel mentioned a session Mike co-chaired on challenges in provider-patient communications. Today, the other co-chair, Shira Zelber-Sagi and panelists Tom Marjot and Jose Willemse join Louise and Mike to return…

1
S5 - E22.6 - FROM THE VAULT: Patient Advocates Reflect On How The "System" Views MASH 12:29

10M ago12:29

12:29

In this week's episode, Jeff Lazarus discusses the idea that the MASH community, including patient advocates, live in a "bit of a bubble," where the clinicians with whom they interact are part of the MASH community. Last year's ICER Public Comments session exposed them to an FDA Advisory Board of hepatologists...and it was a very different experien…

1
S5 - E22.5 - Healthy Livers, Healthy Lives: Watershed Moments To Come In MASLD Publlc Policy 10:49

10M ago10:49

10:49

In this closing conversation, Healthy Livers, Healthy Lives Chair Jeff Lazarus and Surfers Jörn Schattenberg, Louise Campbell and Roger Green discuss the upcoming United Nations General Assembly side event and consider ways listeners can support the "Healthy LIvers, Healthy Lives" coalition. Jeff discussed this impact on global care when the World …

1
S5 - E22.4 - Healthy Livers, Healthy Lives: The Role Of The Updated EASL MASLD Guidelines And Big Data 10:44

10M ago10:44

10:44

Healthy Livers, Healthy Lives Chair Jeff Lazarus joins Jörn Schattenberg, Louise Campbell and Roger Green to discuss the value of the updated EASL/EASD/EASO MASLD clinical practice guidelines and consider the role of Big Data in early MASLD screening. Roger asks Jeff whether he considers the updated MASLD CPG a step forward. Jeff praises the guidel…

1
S5 - E22.3 - Healthy Livers, Healthy Lives: Challenges and Promise in Building a Global MASLD Health Policy 10:54

10M ago10:54

10:54

Healthy Livers, Healthy Lives Chair Jeff Lazarus joins Jörn Schattenberg, Louise Campbell and Roger Green to discuss some of the specific structural challenges that confront global MASLD public policy, along with some promising local activities. Louise observes that, in her experience, primary care practitioners appreciate the support that speciali…

1
S5 - E22.2 - Healthy Livers, Healthy Lives: "Political Will" In MASLD Public Policy 12:14

10M ago12:14

12:14

Healthy Livers, Healthy Lives Chair Jeff Lazarus joins Jörn Schattenberg, Louise Campbell and Roger Green to discuss why political will is so important in overcoming inertia and obstruction in global MASLD public health policy. Louise notes that she left NHS because of obstruction against earlier stage efforts to promote liver health and asks how t…

1
S5 - E22.1 - Healthy Livers, Healthy Lives: Why MASHville Needs This Coalition 13:29

10M ago13:29

13:29

Healthy Livers, Healthy Lives Chair Jeff Lazarus joins Jörn Schattenberg, Louise Campbell and Roger Green to discuss how the coalition came into existence and to describe two initiatves aimed at increasing early screening. Jeff starts the conversation by describing the "bit of a bubble" in which the MASLD community lives: great news and lots of exc…

1
S5 - E22 - Healthy Livers, Healthy Lives: A Global SLD Public Health Coalition 45:08

10M ago45:08

45:08

00:00:00 - Surf's Up: Season 5 Episode 22 Jeff Lazarus joins Jörn Schattenberg, Louise Campbell and Roger Green to discuss Healthy Livers, Healthy Lives, a coalition of four major professional organizations (AASLD, ALEH, APASL and EASL) and other partners. This coalition works with other specialties to create global public health awareness and driv…

1
S5 - E21.6 - From The Vault: Comments On The 2023 AASLD Revised Practice Guidance 11:05

10M ago11:05

11:05

This week's vault conversation looks back 17 months when Ken Cusi joined co-hosts Louise Campbell, Jörn Schatenberg and Roger Green to discuss the revised AASLD Practice Guidance that had been issued the previous week. At the time, here was SurfingMASH's summary of the conversation: Late last week, AASLD published new practice guidance on the clini…

1
S5 - E21.5 - The Updated MASLD CPG: Implications For Healthcare Systems 12:08

10M ago12:08

12:08

In this closing conversation, updated MASLD CPG co-authors Frank Tacke and Elisabetta Bugianesi and podcast co-hosts Louise Campbell and Roger Green consider what the guidelines might foretell in changes in provider education, structure of patient visits and treatment in less affluent or medically advanced countries. The last set of questions begin…

1
S5 - E21.4 - The Updated MASLD CPG: Pharmacology And New Educational Needs 11:04

10M ago11:04

11:04

For most of this conversation, updated MASLD CPG co-authors Frank Tacke and Elisabetta Bugianesi discuss key issues related to pharmacology and prescribing choices. At the end, the focus shifts to the guidelines' overall benefits and some new kinds of education they call for. The conversation starts with co-host Roger Green asking about key issues …

Podcasts Worth a Listen

SurfingNASH.com Podcasts

Podcasts Worth a Listen

Quick Reference Guide